Attention-deficit/hyperactivity disorder diagnosis, co-morbidities, treatment patterns, and quality of life in a pediatric population in central and eastern Europe and Asia

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 4, 2009, Pages 363-376

  Martényi, Ferenc ^a   Treuer, Tamas ^b   Gau, Susan Shur Fen ^c   Hong, Sungdo David ^d   Palaczky, Mária ^e   Šuba, Ján ^f   Tiberiu, Mircea ^g   Uhlíková, Petra ^h   Xu, Tong ⁱ   Zoroǧlu, Salih ^j   Gadow, Kenneth D ^k   Walton, Richard ^l   Harrison, Gavan ^l  

^a ELI LILLY AND COMPANY   (United States)

^b Eli Lilly Area Medical Center   (Austria)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d Sungkyunkwan University   (South Korea)

^e Outpatient Centre for Child Psychiatry   (Hungary)

^f University Children's Hospital   (Slovakia)

^g 10 Iosif Bulbuca   (Romania)

^h NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

ⁱ SECOND MILITARY MEDICAL UNIVERSITY   (China)

^j GAZIANTEP UNIVERSITY   (Turkey)

^k STONY BROOK UNIVERSITY   (United States)

^l ELI LILLY AUSTRALIA PTY LTD   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; MOOD STABILIZER; RISPERIDONE;

ADOLESCENT; AGED; ARTICLE; ASIA; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CHILD; CHILD HEALTH CARE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONDUCT DISORDER; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE SEVERITY; DYSTHYMIA; EASTERN EUROPE; FAMILY THERAPY; FEMALE; GENERALIZED ANXIETY DISORDER; HOMEOPATHY; HUMAN; HYPNOSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSERVATIONAL STUDY; OBSESSIVE COMPULSIVE DISORDER; OCCUPATIONAL THERAPY; OPPOSITIONAL DEFIANT DISORDER; PEDIATRICS; PHASE 4 CLINICAL TRIAL; PHOBIA; PHYSIOTHERAPY; POSTTRAUMATIC STRESS DISORDER; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSYCHOEDUCATION; PSYCHOMOTOR PERFORMANCE; PSYCHOPHYSIOLOGY; PSYCHOTHERAPY; QUALITY OF LIFE; RATING SCALE; RELAXATION TRAINING; SCHIZOPHRENIA; SCHOOL CHILD; SEPARATION ANXIETY; SOCIAL INTERACTION; SOCIAL PHOBIA; SPEECH THERAPY; SUBSTANCE ABUSE;

ADOLESCENT; ASIA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COHORT STUDIES; COMORBIDITY; CROSS-CULTURAL COMPARISON; EUROPE; EUROPE, EASTERN; FEMALE; HUMANS; MALE; POPULATION GROUPS; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 69549107378     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.0148     Document Type: Article

References (44)

1. Alyahri A, Goodman R: The prevalence of DSM-IV psychiatric disorders among 7-10 year old Yemeni schoolchildren. Soc Psychiatry Psychiatr Epidemiol 43:224-230, 2008. (Pubitemid 351338766)
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR). Washington (DC): American Psychiatric Press, 2000.
3. Biederman J, Newcorn J, Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564-577, 1991.
4. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C, Moore P, Spencer T: Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 35:343-351, 1996. (Pubitemid 26072292)
5. Drabick DA, Gadow KD, Carlson GA, Bromet EJ: ODD and ADHD symptoms in Ukrainian children: External validators and comorbidity. J Am Acad Child Adolesc Psychiatry 43:735-743, 2004.
6. Erol N, Simsek Z, Oner O, Munir K. Epidemiology of attention problems among Turkish children and adolescents: A national study. J.Atten.Disord 11:538-545, 2008.
7. Ersan EE, Dogan O, Dogan S, Sumer H: The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey. Eur Child Adolesc Psychiatry 13:354-361, 2004. (Pubitemid 40933125)
8. Escobar R, Soutullo CA, Hervas A, Gastaminza X, Polavieja P, Gilaberte I: Worse quality of life for children with newly diagnosed attention-deficit/ hyperactivity disorder, compared with asthmatic and healthy children. Pediatrics 116:e364-e369, 2005. (Pubitemid 44336649)
9. Faraone SV, Sergeant J, Gillberg C, Biederman J: The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2:104-113, 2003.
10. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS: Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 161:857-864, 2007. (Pubitemid 47360887)
11. Gadow KD, Sprafkin J: Adolescent Symptom Inventory 4, Screening Manual. Stony Brook (New York): Checkmate Plus, 1997.
12. Gadow KD, Sprafkin J: Child Symptom Inventory 4, Screening and Norms Manual. Stony Brook (New York): Checkmate Plus, 2002.
13. Gadow KD, Sprafkin J: The Symptom Inventories: An Annotated Bibliography [On-line]. Stony Brook (New York): Checkmate Plus, 2007. (Available at http://www.checkmateplus.com.)
14. Gadow KD, Nolan EE, Litcher L, Carlson GA, Panina N, Golovakha E, Sprafkin J, Bromet EJ: Comparison of attention-deficit/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren. J Am Acad Child Adolesc Psychiatry 39:1520-1527, 2000.
15. Gau SS, Chong MY, Chen TH, Cheng AT. A 3-year panel study of mental disorders among adolescents in Taiwan. Am J Psychiatry 162:1344-1350, 2005.
16. Gomez R, Harvey J, Quick C, Scharer I, Harris G: DSM-IV AD/HD: Confirmatory factor models, prevalence, and gender and age differences based on parent and teacher ratings of Australian primary school children. J Child Psychol Psychiatry 40:265-274, 1999. (Pubitemid 29078371)
17. Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. Bethesda (Maryland): US Department of Health Education and Welfare, 1976.
18. Ishii T, Takahashi O, Kawamura Y, Ohta T: Comorbidity in attention deficit-hyperactivity disorder. Psychiatry Clin Neurosci 57:457-463, 2003.
19. Johnston C, Mash EJ: Families of children with attention-deficit/ hyperactivity disorder: Reviewand recommendations for future research. Clin Child Fam Psychol Rev 4:183-207, 2001. (Pubitemid 33610771)
20. Klassen AF, Miller A, Fine S: Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics 114:e541-e547, 2004. (Pubitemid 41655750)
21. Lahey BB, Pelham WE, Chronis A, Massetti G, Kipp H, Ehrhardt A, Lee SS: Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children. J Child Psychol Psychiatry 47:472-479, 2006.
22. Manassis K: When attention-deficit/hyperactivity disorder cooccurs with anxiety disorders: Effects on treatment. Expert Rev Neurother 7:981-988, 2007. (Pubitemid 47281312)
23. Mann EM, Ikeda Y, Mueller CW, Takahashi A, Tao KT, Humris E, Li BL Chin D. Cross-cultural differences in rating hyperactive-disruptive behaviors in children. Am J Psychiatry 149:1539-1542, 1992.
24. Matza LS, Secnik K, Mannix S, Sallee FR: Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. Pharmacoeconomics 23:777-790, 2005. (Pubitemid 41420425)
25. Milberger S, Biederman J, Faraone SV, Wilens T, Chu MP: Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict 6:318-329, 1997. (Pubitemid 28005302)
26. Nolan EE, Gadow KD, Sprafkin J: Teacher reports of DSM-IV ADHD, ODD, and CD symptoms in schoolchildren. J Am Acad Child Adolesc Psychiatry 40:241-249, 2001.
27. Norvilitis JM, Fang P: Perceptions of ADHD in China and the United States: A preliminary study. J Atten Disord 9:413-424, 2005.
28. Pastura G, Mattos P, Araujo AP: [Prevalence of attention deficit hyperactivity disorder and its comorbidities in a sample of school-aged children]. Arq Neuropsiquiatr 65:1078-1083, 2007.
29. Pliszka SR: Psychiatric comorbidities in children with attention deficit hyperactivity disorder: Implications for management. Paediatr Drugs 5:741-750, 2003. (Pubitemid 37452623)
30. Prasad S, Harpin V, Poole L, Zeitlin H, Jamdar S, Puvanendran K: A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/ hyperactivity disorder (ADHD). Curr Med Res Opin 23:379-394, 2007. (Pubitemid 46333386)
31. Raggi VL, Chronis AM: Interventions to address the academic impairment of children and adolescents with ADHD. Clin Child Fam Psychol Rev 9:85-111, 2006.
32. Ralston SJ, Lorenzo MJ, ADORE study group: ADORE - Attention-Deficit Hyperactivity Disorder Observational Research in Europe. Eur Child Adolesc Psychiatry 13(Suppl 1):136-142, 2004.
33. Riley AW, Forrest CB, Starfield B, Rebok GW, Robertson JA, Green BF: The Parent Report Form of the CHIP-Child Edition: Reliability and validity. Med Care 42:210-220, 2004.
34. Sciutto MJ, Eisenberg M: Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord 11:106-113, 2007.
35. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME: NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28-38, 2000. (Pubitemid 30029897)
36. Spencer T, Biederman J, Wilens T: Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am 46:915-927, vii, 1999.
37. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP: Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429-433, 1998.
38. Topolski TD, Edwards TC, Patrick DL, Varley P, Way ME, Buesching DP:Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord 7:163-173, 2004. (Pubitemid 38490895)
39. Voeller KK: Attention-deficit hyperactivity disorder (ADHD). J Child Neurol 19:798-814, 2004.
40. Weiss MD, Gadow K, Wasdell MB: Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry 67(Suppl 8):38-45, 2006.
41. World Health Organization (WHO): The ICD-10 classification of mental and behavioral disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
42. Yang P, Hsu HY, Chiou SS, Chao MC: Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: Results from a Taiwanese sample. Aust N Z J Psychiatry 41:998-1004, 2007a. (Pubitemid 350120829)
43. Yang P, Jong YJ, Hsu HY, Tsai JH: Psychiatric features and parenting stress profiles of subtypes of attention-deficit/hyperactivity disorder: Results from a clinically referred Taiwanese sample. J Dev Behav Pediatr 28:369-375, 2007b. (Pubitemid 351326046)
44. Zavadenko NN, Uspenskaia TI., Suvorinova NI: The diagnosis and treatment of the attention deficit syndrome in children. Zh Nevropatol Psikhiatr Im S S Korsakova 97:57-61, 1997. (Pubitemid 127515363)